Company Performance: Financial health, revenue growth, and profitability directly influence investor confidence.

Industry Trends: The performance of the broader healthcare sector and pharmaceutical industry affects sentiment.

Regulatory Changes: Government regulations, drug approvals, and healthcare policies can significantly impact prospects.

Economic Conditions: Overall economic growth, inflation, and interest rates influence investment decisions.

Market Sentiment: General investor optimism or pessimism impacts demand and trading volume.

Competition: The presence of competing drugs and companies affects market share and profitability.

Research & Development: Progress in drug development and successful clinical trials can boost stock value.

Global Events: Geopolitical events, pandemics, and economic crises create volatility.

Dividend Policy: Decisions about dividend payments can attract or deter investors.

Management Team: Competence and reputation of the leadership team influence confidence.